Compounds > mannitol
Page last updated: 2024-08-17

mannitol and Malaria, Falciparum

mannitol has been researched along with Malaria, Falciparum in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's6 (42.86)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dondorp, AM; Plewes, K; Turner, GDH1
Bharadwaj, R; Bhardwaj, R; Chauhan, VS; Chitnis, CE; Dhawan, S; Godbole, G; Gupta, PK; Hans, D; Imbault, N; Kumar, S; Leroy, O; Mazumdar, S; Mehta, S; Mohan, K; Mukherjee, P; Pandey, G; Parulekar, V; Shakri, AR; Shivyogi, P; Singh, B; Singh, K; Yazdani, SS1
Barnwell, JW; Burns, JM; Long, CA; Miura, K; Sullivan, J1
Aebig, J; Durbin, AP; Ellis, RD; Fay, MP; Fontes, E; Lambert, L; Long, C; Mahanty, S; Malkin, EM; Miles, AP; Miller, LH; Miura, K; Muratova, O; Narum, D; Orcutt, A; Rausch, K; Saul, A; Shaffer, D; Song, G; Wu, Y; Zhu, D1
Arnold, M; Ascarateil, S; Ballou, WR; Blythman, H; Cohen, J; de Jonge, E; de Mast, Q; Dubois, MC; Faber, B; Hermsen, R; Imoukhuede, E; Jepsen, S; Kocken, CH; Leroy, O; Ofori-Anyinam, O; Remarque, E; Roeffen, W; Roestenberg, M; Sauerwein, R; Teelen, K; Thomas, A; van der Ven, A; Walraven, V1
Elliott, SL; Ellis, RD; Fay, MP; Long, CA; Malkin, E; Marjason, J; Martin, LB; Miller, LH; Miura, K; Mullen, GED; Pierce, MA; Rausch, K; Tierney, E; Zhu, D1
de Cassan, SC; Dicks, MD; Douglas, AD; Draper, SJ; Gilbert, SC; Hill, AV1
Aebig, J; Dai, W; Ellis, RD; Gebregeorgis, E; Kidwell, MA; Martin, LB; McClellan, H; Miller, L; Rausch, KM; Wu, Y; Zhu, D1
Alves, FA; Bianco, C; Carvalho, LJ; Daniel-Ribeiro, CT; Druilhe, P; Muniz, JA; Oliveira, SG; Soe, S; Theisen, M; Zanini, GM1
Audran, R; Bouzidi, A; Corradin, G; Druilhe, P; Mejia, P; Oeuvray, C; Roussilhon, C; Singh, S; Soesoe, D; Spertini, F1
Cao, Y; Cao, Z; Chen, Z; Gu, J; He, J; Hu, J; Huang, X; Kieny, MP; Li, W; Li, Z; Liu, H; Pan, W; Pan, X; Qu, L; Reed, ZH; Shen, Q; Wan, M; Wang, Q; Xue, X; Zhang, D; Zhang, Q; Zhu, Y1
Ho, M; Looareesuwan, S; Meddings, JB; Vannaphan, S; Wilairatana, P1
Allworth, A; Anders, RF; Anderson, K; Briggs, WR; Brown, GV; Dyer, SL; Irving, DO; Kemp, R; Lawrence, G; Pye, D; Reber, R; Reed, C; Rzepczyk, CM; Saul, A; Schoofs, P; Smillie, A; Stowers, A; Stürchler, D; Taylor, D; Woodrow, GC1
Adiguma, T; Al-Yaman, F; Alpers, MP; Anders, R; Briggs, WR; Brown, G; Genton, B; Giddy, A; Ginny, M; Irving, DO; Mai, A; Pye, D; Rare, L; Reber-Liske, R; Saul, A; Stuerchler, D1

Reviews

1 review(s) available for mannitol and Malaria, Falciparum

ArticleYear
Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria.
    Current opinion in infectious diseases, 2018, Volume: 31, Issue:1

    Topics: Acetaminophen; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Coma; Dexamethasone; Disease Models, Animal; Humans; Kidney; Malaria, Falciparum; Mannitol; Oxidative Stress; Treatment Outcome

2018

Trials

8 trial(s) available for mannitol and Malaria, Falciparum

ArticleYear
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Protozoan; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Female; Hepatitis B Vaccines; Humans; Immunoglobulin G; India; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Merozoite Surface Protein 1; Middle Aged; Oleic Acids; Plasmodium falciparum; Protozoan Proteins

2015
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
    PloS one, 2008, Jul-09, Volume: 3, Issue:7

    Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antigens, Surface; Disease Transmission, Infectious; Female; Humans; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Male; Mannitol; Middle Aged; Oleic Acids; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Recombinant Proteins; Vaccines, Synthetic

2008
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.
    PloS one, 2008, Volume: 3, Issue:12

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Algorithms; Aluminum Hydroxide; Animals; Dose-Response Relationship, Drug; Humans; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Middle Aged; Oleic Acids; Plasmodium falciparum; Treatment Outcome; Vaccines, Synthetic; Young Adult

2008
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults.
    Vaccine, 2010, Mar-02, Volume: 28, Issue:10

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Australia; Dose-Response Relationship, Immunologic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunization, Secondary; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Membrane Proteins; Middle Aged; Oleic Acids; Plasmodium falciparum; Protozoan Proteins; Young Adult

2010
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
    PLoS medicine, 2005, Volume: 2, Issue:11

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibody Formation; B-Lymphocytes; Cell Proliferation; Humans; Immunologic Memory; Malaria Vaccines; Malaria, Falciparum; Mannitol; Oleic Acids; Plasmodium falciparum; T-Lymphocytes

2005
Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults.
    PloS one, 2008, Apr-09, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Female; Humans; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Membrane Proteins; Merozoite Surface Protein 1; Middle Aged; Oleic Acids; Plasmodium falciparum; Protein Subunits; Protozoan Proteins; Recombinant Fusion Proteins; Safety

2008
Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.
    Vaccine, 1999, Aug-06, Volume: 17, Issue:23-24

    Topics: Adjuvants, Immunologic; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Female; Guinea Pigs; Humans; Immunization, Secondary; Lymphocyte Activation; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Mice; Mice, Inbred BALB C; Oleic Acids; Protozoan Proteins; Single-Blind Method; T-Lymphocytes

1999
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.
    Vaccine, 2000, May-22, Volume: 18, Issue:23

    Topics: Adjuvants, Immunologic; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Cytotoxicity, Immunologic; Humans; Immunization, Secondary; Malaria Vaccines; Malaria, Falciparum; Male; Mannitol; Merozoite Surface Protein 1; Middle Aged; Oleic Acids; Papua New Guinea; Plasmodium falciparum; Protozoan Proteins; Safety; T-Lymphocytes; Vaccination

2000

Other Studies

5 other study(ies) available for mannitol and Malaria, Falciparum

ArticleYear
Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Malaria journal, 2016, Mar-15, Volume: 15

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Aotidae; Cross Reactions; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fabaceae; Humans; Malaria Vaccines; Malaria, Falciparum; Mannitol; Merozoite Surface Protein 1; Merozoites; Oleic Acids; Plasmodium falciparum; Protozoan Proteins; Recombinant Fusion Proteins; Treatment Outcome; Vaccines, Subunit; Vaccines, Synthetic

2016
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.
    Vaccine, 2010, Oct-18, Volume: 28, Issue:44

    Topics: Adenoviridae; Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antibody Affinity; CD8-Positive T-Lymphocytes; Female; Immunoglobulin G; Malaria Vaccines; Malaria, Falciparum; Mannitol; Merozoite Surface Protein 1; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oleic Acids; Plasmodium falciparum; Poxviridae

2010
Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide(®) ISA 720 and stabilized with glycine.
    Vaccine, 2011, May-09, Volume: 29, Issue:20

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Drug Stability; Drug Storage; Female; Glycine; Malaria Vaccines; Malaria, Falciparum; Mannitol; Membrane Proteins; Mice; Mice, Inbred BALB C; Oleic Acids; Particle Size; Plasmodium falciparum; Protozoan Proteins; Vaccines, Synthetic

2011
Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
    Clinical and diagnostic laboratory immunology, 2005, Volume: 12, Issue:2

    Topics: Animals; Antigens, Protozoan; Freund's Adjuvant; Lactococcus lactis; Malaria Vaccines; Malaria, Falciparum; Mannitol; Oleic Acids; Protozoan Proteins; Recombinant Fusion Proteins; Saimiri

2005
Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Cell Membrane Permeability; Female; Gastric Mucosa; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Malaria, Falciparum; Male; Mannitol; Sucrose

1997